Search Results

Displaying Results 2151-2175 of 8089 "'III'"

Jun 16, 2026, 06:07 ET GRAL Court Deadline: GRAIL, Inc. Investors are Notified of the Important August 4 Deadline in the Pending Securities Fraud Class Action Lawsuit

Health Service ("NHS"), GRAIL conducted the "NHS-Galleri trial." The primary objective of the NHS-Galleri trial was "to show a reduction in late-stage (III-IV) cancers in people who received the Galleri test compared with those who did not."According to the complaint, during the relevant period, GRAIL

More news about: Bleichmar Fonti & Auld LLP


Jun 16, 2026, 06:00 ET Waterdrop Inc. Announces First Quarter 2026 Unaudited Financial Results

fees, (ii) an increase of RMB38.9 million in the costs for short message service (SMS) costs for new user onboarding and authentication processes; and (iii) an increase of RMB7.3 million in personnel costs. On a quarter-over-quarter basis, operating costs decreased by 28.1% from RMB677.3 million, primarily

More news about: Waterdrop Inc.


Jun 16, 2026, 06:00 ET OLIN and HUNTSMAN Announce Transformative Merger of Equals to Create a $12+ Billion Integrated North American Chemicals Leader

failure to receive, on a timely basis or otherwise, the required approvals of the proposed transaction by Olin's shareholders or Huntsman's stockholders; (iii) the possibility that any or all of the various conditions to the consummation of the proposed transaction may not be satisfied or waived, including

More news about: Olin Corporation; Huntsman Corporation


Jun 16, 2026, 05:00 ET Thurston Group Unites SGA, Gen4, and Modis Under the SGA Dental Partners Banner to Form an Industry-Leading National Dental Support Platform

have ever been part of building, and I'm confident the team leading it will set a new standard for the industry."— Patrick J. Haynes III, Founder, Thurston Group"Dentistry rewards organizations that put doctors first, and over years in this sector we've learned

More news about: SGA Dental Partners


Jun 16, 2026, 03:15 ET Cerillion to Showcase Agentic AI and Product-Led BSS/OSS Innovation at DTW Ignite 2026

TELUS, with EY, Cerillion and Wavelo creating the solution.Hyperconnected intelligent network of trust (HINT) for supply chain – Phase III: This Catalyst explores how terrestrial and non-terrestrial networks, advanced AI and intelligent edge capabilities can be brought together to support

More news about: Cerillion


Jun 15, 2026, 22:09 ET NNOX Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Nano-X Imaging Ltd

demand for its products; (ii) in reality, Nano-X's production and manufacturing operations were poorly aligned with demand for the Company's products; (iii) as a result, Nano-X was experiencing significantly increased operating expenses and cash burn; (iv) the foregoing significantly increased the likelihood

More news about: Robbins LLP


Jun 15, 2026, 21:00 ET Minghui Pharmaceutical Presents Compelling Phase I/II Results for MHB018A, a Novel Subcutaneous Anti-IGF-1R Antibody for Thyroid Eye Disease, in an Oral Presentation at ENDO 2026, the Endocrine Society's Annual Meeting

Grade 1 and no severe or permanent hearing damageMHB018A is being evaluated in ongoing Phase III trials in China, with topline results anticipated in Q3 2026; global Phase III trials have been initiated, with first patient enrollment targeted for Q4 2026SHANGHAI

More news about: Minghui Pharmaceutical


Jun 15, 2026, 20:33 ET GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit

since attested, the trial as executed within the three-year follow-up period was insufficient to demonstrate the achievability of a reduction in Stage III-IV cancers; defendants disclosed the trial period, and thus the screening duration, was apparently insufficient to demonstrate whether the primary endpoint

More news about: THE ROSEN LAW FIRM, P. A.


Jun 15, 2026, 19:45 ET Hybar Announces Pricing of $400,000,000 of Senior Secured Green Notes

mini mill (the "Expansion Mini Mill"), (ii) to fund costs related to the offering of the Notes and other concurrent financing transactions, (iii) to refinance certain existing senior project facilities, and (iv) the remainder, if any, for general corporate purposes.The Notes will be fully

More news about: Hybar LLC


Jun 15, 2026, 19:44 ET Bitmine Immersion Technologies (BMNR) annonce que ses avoirs en ETH atteignent 5,62 millions de jetons et que ses avoirs en cryptomonnaies et en liquidités atteignent 10,4 milliards de dollars

continue de recevoir le soutien d'un groupe d'investisseurs institutionnels de premier plan, dont Cathie Wood d'ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital et l'investisseur privé Thomas « Tom » Lee, pour atteindre l'objectif de Bitmine d'acquérir 5 % du nombre total

More news about: Bitmine Immersion Technologies, Inc.


Jun 15, 2026, 19:01 ET The AI from Skin Analytics that caught 20,000 cancers in the UK is now certified for use on a standard smartphone

using Class III regulated medical device1 technology to deliver autonomous clinical grade skin cancer assessments from a standard smartphone2DERM Zero delivers an autonomous clinical decision directly from a standard smartphone, built on the same Class III regulated

More news about: Skin Analytics


Jun 15, 2026, 19:01 ET La IA que ha detectado 20.000 cánceres en Reino Unido ya está certificada para usarse en smartphone1

DERM Zero es la primera es su clase: apoyándose en una inteligencia artificial como dispositivo médico certificada con el marcado Clase III CE1, evalúa de manera autónoma, con precisión clínica, lesiones de piel potencialmente cancerosas simplemente usando un smartphone convencional.DERM

More news about: Skin Analytics


Jun 15, 2026, 19:01 ET L'IA qui a détecté 20 000 cas de cancer au Royaume-Uni est désormais certifiée pour une utilisation sur un smartphone

réglementé de classe III¹ pour fournir des évaluations autonomes de qualité clinique du cancer de la peau à partir d'un smartphone².DERM Zero fournit une décision clinique autonome directement depuis un smartphone standard, grâce à la même IA réglementée de classe III qui est déployée depuis

More news about: Skin Analytics


Jun 15, 2026, 16:44 ET Le Groupe Menarini présente les résultats de l'essai clinique SENTRY de phase III sur l'association selinexor-ruxolitinib dans le traitement de la myélofibrose lors du congrès 2026 de l'Association européenne d'hématologie (EHA)

recevant l'association contre 28 % dans le groupe témoin à la semaine 24.Une analyse a posteriori de l'essai clinique SENTRY de phase III suggère que la SVR35 pourrait permettre de prédire la survie globale (SG). De nouvelles données issues de l'essai clinique SENTRY de phase I confirment

More news about: Menarini Industrie Farmaceutiche Riunite


Jun 15, 2026, 16:15 ET Suncrete, Inc. Completes Arkansas Acquisition

service. Their local market expertise and strong operational performance will contribute to our continued growth in the region."  Ned N. Fleming, III, Executive Chairman of Suncrete, commented, "This marks our fifth acquisition since going public on April 9th, 2026, consistent with the expectations

More news about: Suncrete, Inc.


Jun 15, 2026, 16:01 ET Natural Grocers® Celebrates Father's Day with Limited-Time Deals and Summer Savings, June 19-21, 2026

excludes taxes and is subject to change without notice. Natural Grocers reserves the right to correct errors. Void where prohibited by law.[iii] Limit 1 per {N}power account. In-store only on 6/21/26. Click to load the free meat or fruit strip offer to {N}power account from the Natural

More news about: Natural Grocers by Vitamin Cottage, Inc.


Jun 15, 2026, 16:00 ET High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

dividing gross profit by revenue.iii.Adjusted gross margin is a non-IFRS financial measure.

More news about: High Tide Inc.


Jun 15, 2026, 15:09 ET SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--CZNL, NSA, CNBN, and ESQ

completion of the proposed transaction, CNB shareholders will receive either (i) 1.0434 shares of HBT common stock, (ii) $27.73 in cash per share, or (iii) a combination of cash and shares of HBT common stock.Click here for more information

More news about: Monteverde & Associates PC


Jun 15, 2026, 14:35 ET /C O R R E C T I O N -- Kootenay Silver Inc./

facility at La Cigarra. ii Consensus metal prices of $50.00/oz Ag, $3,611/oz Au, $0.91/lb Pb, and $1.25/lb Zn. iii Spot metal prices of $67.23/oz Ag, $4,210/oz Au, $0.91/lb Pb, and $1.57/lb Zn.Correction: The first paragraph

More news about: Kootenay Silver Inc.


Jun 15, 2026, 12:31 ET EGFR Inhibitors Market to Witness Upsurge in Growth at a CAGR of 7.9% During the Forecast Period (2026-2036) Owing to the Entry of Next-generation TKIs, ADCs, and Combination Strategies with Immunotherapy| DelveInsight

others.Akeso's ivonescimab (AK112, SMT112) is a novel PD-1/VEGF bispecific antibody and the first agent of its kind to advance into Phase III clinical testing. Developed using the company's proprietary Tetrabody platform, the therapy is designed to simultaneously inhibit PD-1 interactions with

More news about: DelveInsight Business Research, LLP


Jun 15, 2026, 11:30 ET Gutter Capital Announces $75M Fund III, Opens Applications for Elbow Grease Accelerator

Elbow Grease, the firm's small-batch accelerator in New York City, sponsored by Mercury and Orrick, alongside the close of Fund III at $75M.

More news about: Gutter Capital


Jun 15, 2026, 09:30 ET GRAL INVESTOR NOTICE: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

reduction in Stage III-IV cancers in Grail's NHS-Galleri trial, while also concealing material adverse facts which reduced the possibility of such an outcome; (ii) in truth, Grail's optimism in achieving the primary endpoint of its NHS-Galleri study fell short of reality; and (iii) the confidence management

More news about: Robbins Geller Rudman & Dowd LLP


Jun 15, 2026, 09:17 ET Bitmine Immersion Technologies (BMNR) Công Bố Lượng ETH Nắm Giữ Đạt 5,62 Triệu Token, Đưa Tổng Tài Sản Tiền Mã Hóa và Tiền Mặt Lên Mức 10,4 Tỷ USD

Bitmine hiện vẫn được hỗ trợ bởi một nhóm các nhà đầu tư tổ chức hàng đầu như Cathie Wood của ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital và nhà đầu tư cá nhân Thomas "Tom" Lee nhằm giúp Bitmine đạt mục tiêu sở hữu 5% ETHNORWALK,

More news about: Bitmine Immersion Technologies, Inc.


Jun 15, 2026, 09:15 ET Bitmine Immersion Technologies (BMNR) anuncia que sus tenencias de ETH alcanzan los 5,62 millones de tokens

con el respaldo de un selecto grupo de inversores institucionales, entre los que se incluyen Cathie Wood de ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital y el inversor particular Thomas "Tom" Lee, para apoyar el objetivo de Bitmine de adquirir el 5% de ETH.

More news about: Bitmine Immersion Technologies, Inc.


Jun 15, 2026, 08:47 ET Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs

Proteomic analysis of canine vaccines. Am J Vet Res. 2023;84(3):ajvr.22.11.0192. Published 2023 Jan 24. doi:10.2460/ajvr.22.11.0192iii Ohmori K, Masuda K, Maeda S, et al. IgE reactivity to vaccine components in dogs that developed immediate type allergic reactions after vaccination.

More news about: Elanco Animal Health


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.